ASND logo

Ascendis Pharma A/S (ASND) Selling, General & Administrative Expenses

Annual SGA

$307.98 M
+$27.81 M+9.93%

December 31, 2024


Summary


Performance

ASND SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherASNDexpensesmetrics:

Quarterly SGA

$83.98 M
+$9.05 M+12.08%

December 31, 2024


Summary


Performance

ASND Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherASNDexpensesmetrics:

TTM SGA

N/A

December 31, 2024


Summary


Performance

ASND TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherASNDexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

ASND Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.9%+5.0%-
3 y3 years+62.5%+5.0%-
5 y5 years+467.5%+5.0%-

ASND Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+62.5%at high+60.5%
5 y5-yearat high+467.5%at high+344.1%
alltimeall timeat high+9498.2%at high>+9999.0%

Ascendis Pharma A/S Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$307.98 M(+9.9%)
$83.98 M(+12.1%)
$311.46 M(+5.8%)
Sep 2024
-
$74.93 M(-6.4%)
$294.39 M(+2.4%)
Jun 2024
-
$80.02 M(+10.3%)
$287.52 M(+1.2%)
Mar 2024
-
$72.54 M(+8.4%)
$284.14 M(+0.4%)
Dec 2023
$280.17 M(+23.1%)
$66.90 M(-1.7%)
$283.07 M(+5.4%)
Sep 2023
-
$68.06 M(-11.2%)
$268.49 M(+2.7%)
Jun 2023
-
$76.64 M(+7.2%)
$261.55 M(+6.7%)
Mar 2023
-
$71.47 M(+36.6%)
$245.18 M(+8.0%)
Dec 2022
$227.63 M(+20.1%)
$52.33 M(-14.4%)
$226.93 M(-1.3%)
Sep 2022
-
$61.12 M(+1.4%)
$229.84 M(+6.9%)
Jun 2022
-
$60.27 M(+13.3%)
$215.04 M(+9.0%)
Mar 2022
-
$53.21 M(-3.7%)
$197.37 M(+4.4%)
Dec 2021
$189.52 M(+116.5%)
$55.25 M(+19.3%)
$189.04 M(+19.5%)
Sep 2021
-
$46.32 M(+8.7%)
$158.15 M(+19.5%)
Jun 2021
-
$42.60 M(-5.1%)
$132.33 M(+17.5%)
Mar 2021
-
$44.88 M(+84.3%)
$112.64 M(+28.7%)
Dec 2020
$87.56 M(+61.4%)
$24.35 M(+18.8%)
$87.53 M(+6.6%)
Sep 2020
-
$20.49 M(-10.6%)
$82.08 M(+12.9%)
Jun 2020
-
$22.91 M(+15.9%)
$72.71 M(+17.1%)
Mar 2020
-
$19.77 M(+4.5%)
$62.11 M(+14.6%)
Dec 2019
$54.27 M
$18.91 M(+70.1%)
$54.20 M(+20.9%)
Sep 2019
-
$11.12 M(-9.7%)
$44.84 M(+7.7%)
Jun 2019
-
$12.31 M(+3.9%)
$41.62 M(+17.1%)
DateAnnualQuarterlyTTM
Mar 2019
-
$11.85 M(+24.1%)
$35.55 M(+20.8%)
Dec 2018
$29.59 M(+93.8%)
$9.55 M(+20.9%)
$29.42 M(+19.2%)
Sep 2018
-
$7.90 M(+26.6%)
$24.68 M(+22.7%)
Jun 2018
-
$6.24 M(+9.0%)
$20.12 M(+15.4%)
Mar 2018
-
$5.73 M(+19.0%)
$17.43 M(+14.3%)
Dec 2017
$15.27 M(+19.9%)
$4.81 M(+44.1%)
$15.25 M(+9.1%)
Sep 2017
-
$3.34 M(-6.1%)
$13.98 M(+2.9%)
Jun 2017
-
$3.56 M(+0.4%)
$13.59 M(+4.1%)
Mar 2017
-
$3.54 M(-0.1%)
$13.05 M(+2.6%)
Dec 2016
$12.73 M(+21.9%)
$3.54 M(+20.3%)
$12.72 M(-1.9%)
Sep 2016
-
$2.95 M(-2.2%)
$12.97 M(+12.1%)
Jun 2016
-
$3.02 M(-6.0%)
$11.57 M(+5.9%)
Mar 2016
-
$3.21 M(-15.5%)
$10.93 M(+4.7%)
Dec 2015
$10.45 M(+25.2%)
$3.80 M(+144.7%)
$10.43 M(+8.8%)
Sep 2015
-
$1.55 M(-34.5%)
$9.59 M(-5.1%)
Jun 2015
-
$2.37 M(-12.7%)
$10.10 M(+4.5%)
Mar 2015
-
$2.71 M(-8.2%)
$9.66 M(+17.2%)
Dec 2014
$8.34 M(+160.0%)
$2.95 M(+43.3%)
$8.24 M(+36.5%)
Sep 2014
-
$2.06 M(+6.9%)
$6.04 M(+51.9%)
Jun 2014
-
$1.93 M(+49.1%)
$3.98 M(+94.3%)
Mar 2014
-
$1.29 M(+72.3%)
$2.05 M(+172.3%)
Dec 2013
$3.21 M(-7.2%)
$751.40 K
$751.40 K
Dec 2012
$3.46 M
-
-

FAQ

  • What is Ascendis Pharma A/S annual SGA?
  • What is the all time high annual SGA for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual SGA year-on-year change?
  • What is Ascendis Pharma A/S quarterly SGA?
  • What is the all time high quarterly SGA for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly SGA year-on-year change?
  • What is the all time high TTM SGA for Ascendis Pharma A/S?

What is Ascendis Pharma A/S annual SGA?

The current annual SGA of ASND is $307.98 M

What is the all time high annual SGA for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual SGA is $307.98 M

What is Ascendis Pharma A/S annual SGA year-on-year change?

Over the past year, ASND annual SGA has changed by +$27.81 M (+9.93%)

What is Ascendis Pharma A/S quarterly SGA?

The current quarterly SGA of ASND is $83.98 M

What is the all time high quarterly SGA for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly SGA is $83.98 M

What is Ascendis Pharma A/S quarterly SGA year-on-year change?

Over the past year, ASND quarterly SGA has changed by +$3.96 M (+4.95%)

What is the all time high TTM SGA for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high TTM SGA is $556.61 M